Cheng Wang

发表论文 50 篇 · 总被引 2404 次 · h-index 28

代表论文

• Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies. (2023 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 被引 129)
• Cucurbitacin B: A Review of its Pharmacology, Toxicity, and Pharmacokinetics. (2022 · Pharmacological Research · 被引 101)
• CD44‐Targeting Drug Delivery System of Exosomes Loading Forsythiaside A Combats Liver Fibrosis via Regulating NLRP3‐Mediated Pyroptosis (2023 · Advanced Healthcare Materials · 被引 76)
• Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies. (2023 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 被引 69)
• Phillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p. (2023 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 被引 57)
• Forsythiaside A alleviated carbon tetrachloride-induced liver fibrosis by modulating gut microbiota composition to increase short-chain fatty acids and restoring bile acids metabolism disorder. (2022 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 被引 52)